FDA approves Akorn's copy of painkiller Dilaudid-HP

04/15/2010 | Bloomberg Businessweek

Akorn said it obtained FDA approval for its generic version of pain drug Dilaudid-HP and will begin to distribute the product next month. The approval comes as Akorn starts producing an injectable formulation of the antibiotic vancomycin HCL through a joint venture with Strides Arcolab.

View Full Article in:

Bloomberg Businessweek

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Counsel – Regulatory Affairs
RAI Services Company
Winston-Salem, NC
Senior Counsel Commercial
RAI Services Company
Winston Salem, NC
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL